DTIC-DOME -PWS IV 200MG/VIAL DIN 02154854
Health Canada record
| Active ingredient(s) | DACARBAZINE 10 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AX04 DACARBAZINE |
| Original market date | 10-Oct-1996 |
| Current status date | 31-May-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bayer Inc — licence 101029, currently licensed, last inspection rating C (2023-02-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DACARBAZINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02566702 | DACARBAZINE FOR INJECTION | STERIMAX INC | Powder For Solution | DACARBAZINE 200 MG | Approved |
| 02566710 | DACARBAZINE FOR INJECTION | STERIMAX INC | Powder For Solution | DACARBAZINE 500 MG | Approved |
| 02241445 | DACARBAZINE FOR INJECTION BP | PFIZER CANADA ULC | Powder For Solution | DACARBAZINE 600 MG | Marketed |
| 00521183 | DTIC DOME INJ 200MG/VIAL | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Liquid | DACARBAZINE 200 MG | Cancelled Post Market |
International API supply for DACARBAZINE
3 valid EDQM Certificates of Suitability from 3 holders. 3 active FDA Drug Master Files.
Request a quote for DTIC-DOME -PWS IV 200MG/VIAL